13F HOLDINGS REPORT
Essex Woodlands Management, Inc.
Quarter ended Q1 2023 · Filed February 14, 2023 · Accession 0001398344-23-003145
Total Value
$179.3M
Positions
7
Other Managers
0
Confidential Omitted
No
Holdings (7)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | MIMEDX GROUP, INC. | MDXG | 23,415,584 | $65.1M | 36.30% |
| 2 | TELA BIO, INC. | TELA | 4,110,709 | $47.3M | 26.36% |
| 3 | BIOVENTUS | BVS | 12,096,702 | $31.6M | 17.60% |
| 4 | EYEPOINT PHARMACEUTICALS INC | EYPT | 4,190,921 | $14.7M | 8.18% |
| 5 | VENUS CONCEPT, INC. | VERO | 31,337,856 | $10.0M | 5.59% |
| 6 | REVANCE THERAPEUTICS INC | 761330109 | 457,085 | $8.4M | 4.70% |
| 7 | MEDICINOVA INC | MNOV | 1,105,941 | $2.3M | 1.26% |